Seymour, J. F., Byrd, J. C., Munir, T., Ghia, P., Kater, A. P., Chanan-Khan, A., Furman, R. R., O’Brien, S., Brown, J. R., Mato, A. R., Stilgenbauer, S., Fehn, T., de Miranda, P. A. P., Higgins, K., John, E., de Borja, M., Jurczak, W., & Woyach, J. A. (2022). Assessing the Burden of Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL). Blood, 140(Supplement 1), 7050–7052. https://doi.org/10.1182/blood-2022-157060